Britt Gambino

The American College of Physicians (ACP) released a statement supporting an “immediate ramping up of supply for distribution of COVID-19 vaccines equitably among and within countries in need.”

Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.

A first look at what will be presented at this year’s American Academy of Neurology annual meeting.

Although renal cysts are generally thought of as benign findings, this study points to a possible higher stroke risk in patients with multiple cysts.

Fixed-dose candesartan plus hydrochlorothiazide and rosuvstatin reduced first stroke in patients at intermediate risk for cardiovascular disease.

In this population-based study, researchers found that Mexican Americans had a greater risk for recurrent stroke and death than non-Hispanic whites.

Researchers have observed an upward trend in the incidence of pregnancy-related spontaneous subarachnoid hemorrhage.

The ACC released a new concensus on guiding clinicians in managing acute bleeding for patients treated with OACs.

Patients with multiple sclerosis who experience severe fatigue should be screened for obstructive sleep apnea.

The Penumbra 3D revascularization device was recalled by the FDA because of a risk of the delivery wire breaking during use.

Shorter sleep duration may increase mortality risks associated with both cardiovascular and cerebrovascular disease.

Mortality among women with preeclampsia and pregnancy-associated stroke was significantly higher than in controls.

Higher glucose levels reduce likelihood of good outcome among stroke patients with good collaterals.

Recurrent fatal or nonfatal VTE occurred in 1.5% of patients who took 20 mg of rivaroxaban, 1.2% of patients who took 10 mg, and 4.4% who took aspirin.

Previous research has suggested that statins and PCSK9 inhibitors may adversely affect cognition.

Efficacy of triple antiplatelet therapy compared with current guideline-based therapy for the prevention of recurrent stroke was evaluated in the TARDIS trial.

Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.

The results provide good evidence for the use of contact aspiration in ischemic stroke.

Pulmonary embolism risk was lowest in patients with cerebral venous thromboembolism during the index hospitalization.

Amyloid beta protein accumulation was present in the hearts of patients with Alzheimer’s disease.

The study was underpowered to detect differences in all-cause mortality and stroke.

Overall, men had smoked longer, more daily, and their total exposure in pack-years was greater than women.

Higher LDL-C variability was associated with lower cognitive test scores, including immediate and delayed recall.

In the SOCRATES trial, patients were randomly assigned to ticagrelor or aspirin for 90 days.

Communication and coordination among the healthcare team are essential for a stroke patient’s survival.

Participants with 2 to 7 ideal CVH factors had less cognitive decline compared with those with only 0 to 1 factors.

Patients with atrial fibrillation treated with LAA closure may experience more quality-adjusted-life-years vs those treated with warfarin.

The FDA has issued a safety communication for medical devices used in intravascular procedures.